topic-04002006 News Coverage on Pharmaceutical Industry - CTNow
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 89-99
  • Shire confirms in talks with AbbVie on takeover bid

    Shire confirms in talks with AbbVie on takeover bid
    Shire Plc on Friday confirmed it has held a meeting with U.S. drugmaker AbbVie Inc to discuss AbbVie's takeover bid for the Dublin-based maker of drugs for rare diseases. Shire, in a release, said it would provide a further update "when appropriate." It...
  • Abbott to sell generics in major markets to Mylan for $5.3 billion

    Abbott to sell generics in major markets to Mylan for $5.3 billion
    Abbott Laboratories has agreed to sell its specialty and branded generic pharmaceutical business in developed markets to Pennsylvania-based Mylan Inc. in an all-stock transaction valued at about $5.3 billion. The deal, which will give Abbott a roughly...
  • MannKind shares surging on optimism about inhaled insulin drug

    MannKind shares surging on optimism about inhaled insulin drug
    MannKind Corp. shares were surging on the first full day of trading since the Food and Drug Administration approved the Valencia company’s inhaled insulin treatment for people with diabetes. Late Friday, the FDA announced that it had approved...
  • MannKind wins long sought FDA approval for insulin inhaler

    MannKind wins long sought FDA approval for insulin inhaler
    Los Angeles billionaire-inventor Alfred Mann's almost decade-long quest to develop an inhalable form of insulin for diabetics won approval Friday from U.S. regulators. His company, MannKind Corp. of Valencia, got the OK on Friday to sell the drug called...
  • Abbott, AbbVie part of red-hot pharmaceutical deal market

    AbbVie Inc. appears to be on the verge of a $53.7 billion takeover that would change its corporate address to the United Kingdom. Abbott Laboratories agreed Monday to sell part of its generic drug business for $5.3 billion, structuring the sale in a way...
  • Baxter has no plans for inversion with spinoff

     Baxter has no plans for inversion with spinoff
    While its peers in the northern suburbs and around the pharmaceutical industry have been lining up foreign mergers to help sidestep U.S. taxes, Baxter International said Thursday it has no plans to jump on the bandwagon. The Deerfield-based health...
  • AbbVie to Buy Shire for $54.8 billion in biggest inversion

    AbbVie to Buy Shire for $54.8 billion in biggest inversion
    AbbVie Inc. is buying Shire for nearly $55 billion, the largest deal in a year filled with merger and acquisition activity, and the latest example of companies taking foreign addresses to cut taxes. The deal will allow North Chicago-based pharmaceutical...
  • AbbVie to buy drugmaker Shire in nearly $55 billion deal

    AbbVie to buy drugmaker Shire in nearly $55 billion deal
    AbbVie Inc. has inked a nearly $55 billion deal to acquire drugmaker Shire PLC, the companies announced in a joint statement Friday morning. The deal, the largest of a year filled with merger and acquisition activity, will allow the North Chicago-...
  • AbbVie-Shire deal puts more pressure on Congress to overhaul tax code

    A massive pharmaceutical merger that will send the headquarters of a major U.S. drug maker overseas ramps up pressure on Congress to curtail the ability of companies to shelter foreign earnings. Illinois drug maker AbbVie Inc. said Friday that it...
  • Capital BlueCross banned from enrolling new Medicare members

    Capital BlueCross banned from enrolling new Medicare members
    Federal authorities have banned Capital BlueCross from enrolling new customers into its Medicare plans, saying the health insurance company denied some seniors coverage for emergency services and access to prescription drugs, and overcharged about 3,000...
  • Charles Farthing dies at 60; doctor at forefront of AIDS care

    Charles Farthing dies at 60; doctor at forefront of AIDS care
    Charles F. Farthing, a physician who was at the forefront of care for HIV/AIDS patients and who drew attention to the need for an AIDS vaccine by announcing his willingness to inject himself, has died. He was 60. Farthing, who collapsed in a Hong Kong...